Search

In recent years, antioxidant supplements have become popular to counteract the effects of oxidative stress in fibromyalgia and one of its most distressing symptoms, pain. The aim of this systematic review was to summarize the effects of antioxidant supplementation on pain levels perceived by patients diagnosed with fibromyalgia. The words used respected the medical search terms related to our objective including antioxidants, fibromyalgia, pain, and supplementation. Seventeen relevant articles were identified within Medline (PubMed), Scopus, Web of Science (WOS), the Cochrane Database of Systematic Review, and the Cochrane Central Register of Controlled Trials. This review found that antioxidant supplementation is efficient in reducing pain in nine of the studies reviewed. Studies with a duration of supplementation of at least 6 weeks showed a benefit on pain perception in 80% of the patients included in these studies. The benefits shown by vitamins and coenzyme Q10 are remarkable. Further research is needed to identify the effects of other types of antioxidants, such as extra virgin olive oil and turmeric. More homogeneous interventions in terms of antioxidant doses administered and duration would allow the effects on pain to be addressed more comprehensively.

The aim of this review was to demonstrate the presence of categories and subcategories of Mishel's model in the experiences of patients with fibromyalgia by reviewing qualitative studies. Uncertainty is defined as the inability to determine the meaning of disease-related events. A scoping review of qualitative studies was carried out. Twenty articles were included, with sample sizes ranging from 3 to 58 patients. Articles from different countries and continents were included. Three categories of the model and eight subcategories could be shown to be present in the experiences of fibromyalgia patients through the scoping review. The first category, concerning antecedents of uncertainty in patients with fibromyalgia, is constituted by the difficulty in coping with symptoms, uncertainty about the diagnosis and uncertainty about the complexity of the treatment. The second concerns the cognitive process of anxiety, stress, emotional disorder and social stigma. The third category refers to coping with the disease, through the management of social and family support and the relationship with health care professionals., Competing Interests: The authors declare no conflict of interest

Objective: The aim of this article is to translate and adapt the Mishel uncertainty scale to the Spanish context., Method: A cross-sectional study for transcultural adaptation and validation of the Mishel uncertainty scale. The study population were patients with chronic renal disease treated with hemodialysis. The original English version of the "Mishel uncertainty in illness scale" was translated into Spanish, then back-translated into English, and all the discrepancies were resolved after consulting with experts. A panel including 11 experts in renal care assessed this culturally adapted Spanish version, in order to score the content validity. It was administered to 116 patients in order to calculate the psychometric properties scale. Construct validity was calculated using factor analysis, and internal consistency using Cronbach's alpha coefficient. Relationships between variables related to the main theory were analyzed., Results: The Spanish version has 17 items, distributed in 2 dimensions: ambiguity and complexity. A content validity index average of 0.7 and a Cronbach's alpha 0.72. Statistically significant association was found between uncertainty, gender, educational level and disease relapse., Conclusions: Cross-cultural adaptation of the Mishel uncertainty in illness scale preserves equivalence with the original. Content validation identified most useful items for chronic renal patients. The multidimensional nature of the scale is reaffirmed. The association between uncertainty and the level of education is also confirmed., (Copyright © 2014 Elsevier España, S.L.U. All rights reserved.)